#vaccine

FDA Authorizes Pfizer Booster Shots for Young Teens as Omicron Surges

D. Brit

Jan 3, 2022
1 min

FDA Authorizes Pfizer Booster Shots for Young Teens as Omicron Surges

What Happened: On Monday, the Food and Drug Administration approved the use of Pfizer's Covid-19 vaccine booster shot for children as young as 12. Booster shots had already been approved for everyone 16 and older. The FDA also said everyone 12 or older may receive their booster shot as early as five months after their last dose, rather than the original six months. Said FDA vaccine chief, Dr. Peter Marks, the decision was made because the booster shots "may help provide bette

6 views0 comments

CDC Recommends Pfizer and Moderna Vaccines Over J&J Vaccine

D. Brit

Dec 17, 2021
1 min

CDC Recommends Pfizer and Moderna Vaccines Over J&J Vaccine

What Happened: On Thursday, the Center for Disease Control and Prevention (CDC) recommended that adults opt to take the Pfizer or Moderna Covid-19 vaccines over the Johnson & Johnson vaccine, if the choice is available. The CDC made the recommendation because some patients have developed a rare blood clot condition after taking the Johnson & Johnson vaccine. Although the rate of occurrence with the J&J vaccine is very rare, only 3.8 cases per million doses administered, the C

6 views0 comments

FDA Authorizes Covid-19 Booster Shots for Seniors and High-Risk Patients

D. Brit

Sep 22, 2021
1 min

FDA Authorizes Covid-19 Booster Shots for Seniors and High-Risk Patients

What Happened: On Wednesday, the Food and Drug Administration approved the use of Covid-19 vaccine booster shots for seniors aged 65 and older and for high-risk patients. The Biden administration wishes to administer booster shots to nearly all American adults to help combat the spread of the highly contagious Delta variant, however, the FDA says there are still too many uncertainties and, thus far, has rejected Biden's plan. FDA commissioner Dr. Janet Woodcock said that the

7 views0 comments

Covid Vaccines for Military Will Be Mandatory Under New Plan

D. Brit

Aug 9, 2021
1 min

Covid Vaccines for Military Will Be Mandatory Under New Plan

What Happened: In a new plan announced by the Pentagon on Monday, military personnel will be required to get the Covid-19 vaccine starting on Sept. 15th. Defense Secretary Lloyd Austin said the deadline could be pushed up if one of the vaccines gets final FDA approval before that date. Said Austin, “To defend this Nation, we need a healthy and ready force.” In a statement on Monday, President Biden said he strongly supports Austin’s plan. Photo Source: Pixabay #newspura #jus

6 views0 comments

CDC and FDA Pause Usage of Johnson & Johnson Vaccine - Citing Concerns Over Rare Blood Clots

D. Brit

Apr 13, 2021
1 min

CDC and FDA Pause Usage of Johnson & Johnson Vaccine - Citing Concerns Over Rare Blood Clots

What Happened: On Tuesday, the Center for Disease Control and Food and Drug Administration announced that they are recommending that the United States pause usage of the Johnson & Johnson Covid-19 vaccine, citing concerns over "rare and severe" blood clots. So far, there are six reported cases of these severe blood clots. Developing Story Photo Source: pixabay #newspura #justfactsnoopinions #covid19 #coronavirus #vaccine #johnsonandjohnson #oneshotvaccine #news #breaking #bre

12 views0 comments

UK Recommends That People Under 30 Not Take AstraZeneca Vaccine Amid Blood Clot Concerns

D. Brit

Apr 7, 2021
1 min

UK Recommends That People Under 30 Not Take AstraZeneca Vaccine Amid Blood Clot Concerns

What Happened: On Wednesday, the United Kingdom joined other countries in restricting the use of AstraZeneca’s COVID-19 vaccine in people under 30, citing concerns over unusual blood clot formations in a small number of cases. Authorities continue to say that the benefits of the vaccine outweigh the risks for most people, however, they recommended that people under 30 be offered alternatives to AstraZeneca. The move comes a few weeks after the European Medicines Agency concl

13 views0 comments

Biden To Announce Vaccine Eligibility By April 19th For All Adults

D. Brit

Apr 6, 2021
1 min

Biden To Announce Vaccine Eligibility By April 19th For All Adults

What's Happening: According to several sources, President Biden will announce Tuesday that he is moving up the vaccine eligibility date for all adults by about two weeks. The original date was May 1, but with states expanding eligibility, the new deadline will now be April 19. Eligibility means that as of April 19, all Americans over the age of 16 will be able to schedule their vaccination. President Biden is also expected to announce that 150 million Americans have received

10 views0 comments

AstraZeneca Updates Data - Vaccine 76% Effective

D. Brit

Mar 24, 2021
2 min

AstraZeneca Updates Data - Vaccine 76% Effective

What Happened: On Wednesday, AstraZeneca updated the data from their late-stage US trials saying that their Covid-19 vaccine is 76% effective at preventing symptomatic Covid-19 (down slightly from the 79% they originally reported on Monday) and 100% effective at preventing severe symptoms and hospitalizations. The company added that the vaccine is 85% effective in preventing symptoms in people 65 and older. On Tuesday, the Data and Safety Monitoring Board (DSMB) expressed con

5 views0 comments

US Trials Show AstraZeneca Vaccine To Be 79% Effective

D. Brit

Mar 22, 2021
1 min

US Trials Show AstraZeneca Vaccine To Be 79% Effective

What Happened: On Monday, AstraZeneca revealed that late-stage US trials showed their Covid-19 vaccine to be 79% effective at preventing symptomatic Covid-19 and 100% effective at preventing severe symptoms and hospitalizations. AstraZeneca added that the trials did not demonstrate any safety concerns including blood clots (a concern that was recently brought up by several countries). Although the AstraZeneca vaccine is already being used in more than 50 countries, it has not

6 views0 comments

Astra-Zeneca Vaccine Suspended In Several European Countries Over Blood Clot Concerns

D. Brit

Mar 15, 2021
1 min

Astra-Zeneca Vaccine Suspended In Several European Countries Over Blood Clot Concerns

What Happened: Several European nations have suspended use of Astra-Zeneca's Covid-19 vaccine over concerns of potential subsequent health complications such as blood clots. Denmark, Iceland and Norway were some of the first to halt use of the vaccine last week. Thailand, Bulgaria, Germany, France, and Italy have also suspended use of the vaccine pending further investigation. Astra-Zeneca has said there is no data that suggests a link between their vaccine and any serious si

6 views0 comments

Biden to Purchase 100 Million More Doses of J&J Vaccine

D. Brit

Mar 10, 2021
1 min

Biden to Purchase 100 Million More Doses of J&J Vaccine

What Happened: According to multiple sources, President Biden will announce on Wednesday that he is directing the US Dept. of Health and Human Services to purchase an additional 100 million doses of the Johnson & Johnson Covid-19 Vaccine. A timeline of when the additional vaccines will be delivered is still unavailable. In a deal brokered by the White House, pharmaceutical giants Merck and Johnson & Johnson have been working together to produce J&J's vaccine. President Biden

6 views0 comments

FDA Authorizes Johnson & Johnson Covid-19 Vaccine for Emergency Use

D. Brit

Feb 27, 2021
1 min

FDA Authorizes Johnson & Johnson Covid-19 Vaccine for Emergency Use

What Happened: On Saturday, the FDA authorized the Johnson & Johnson Covid-19 vaccine for emergency use authorization. Said White House Senior for Covid-19 Response, Andy Slavitt, "A third safe and effective vaccine is very welcome news." Johnson & Johnson says they can begin delivering the vaccine next week. The vaccine is the first single-dose vaccine authorized to treat the virus. The J&J vaccine was found to be 66.9% effective at preventing moderate to severe Covid-19 sym

10 views0 comments

FDA Advisers Recommend J&J Vaccine Receive Emergency Use Authorization

D. Brit

Feb 26, 2021
1 min

FDA Advisers Recommend J&J Vaccine Receive Emergency Use Authorization

What Happened: On Friday, a panel of vaccine advisers to the FDA recommended that the agency grant emergency use authorization for the Johnson & Johnson Covid-19 vaccine. The FDA's Vaccine and Related Biological Products Advisory Committee voted unanimously in favor of approving the J&J vaccine for emergency use in people 18 or older. The FDA is expected to act on the recommendation quickly. If approved, the Johnson and Johnson vaccine would become the third Covid-19 vaccine

3 views0 comments

FDA Says J&J Vaccine Meets Requirements For Emergency Use Authorization

D. Brit

Feb 24, 2021
1 min

FDA Says J&J Vaccine Meets Requirements For Emergency Use Authorization

What Happened: On Wednesday, the FDA announced that the Johnson & Johnson Covid-19 vaccine has met the requirements necessary for emergency use authorization. If approved, it would be the first single-dose vaccine authorized to treat the virus. The Johnson & Johnson vaccine was found to be 66.9% effective at preventing moderate to severe Covid-19 symptoms and 85% effective against very serious symptoms. The J&J vaccine was less effective against the mutated South African ver

13 views0 comments

Johnson & Johnson Seeks Emergency Use Authorization for Vaccine

D. Brit

Feb 4, 2021
1 min

Johnson & Johnson Seeks Emergency Use Authorization for Vaccine

What Happened: On Thursday, Johnson & Johnson asked US regulators to approve emergency use authorization of its Covid-19 vaccine. If approved, it would be the first single-dose vaccine authorized to treat the virus. Last Friday, Johnson & Johnson revealed that their one-shot Covid-19 vaccine is 66% effective at preventing moderate to severe Covid-19 symptoms and 85% effective against very serious symptoms. The J&J vaccine was less effective against the mutated South African v

7 views0 comments

Interim Trials Show Russian Sputnik V Vaccine To Be 91.6% Effective

D. Brit

Feb 2, 2021
1 min

Interim Trials Show Russian Sputnik V Vaccine To Be 91.6% Effective

What Happened: According to an interim analysis, Russia's Sputnik V Covid-19 vaccine has been shown to be 91.6% effective against symptomatic Covid-19 and 100% effective against severe and moderate disease. The findings were released by The Lancet on Tuesday and based on roughly 20,000 participants. Criticized for its early rollout before Phase 3 trials were complete, the Sputnik V vaccine is a two-dose adenoviral vaccine using different adenoviruses for each dose. This is s

7 views0 comments

Johnson & Johnson Introduces First One-Shot Vaccine

D. Brit

Jan 29, 2021
1 min

Johnson & Johnson Introduces First One-Shot Vaccine

What Happened: In a study released on Friday, Johnson & Johnson revealed that their one-shot Covid-19 vaccine is 66% effective at preventing moderate to severe Covid-19 symptoms and 85% effective against very serious symptoms. The J&J vaccine was less effective against the mutated South African version of the virus. J&J says they plan to seek emergency use authorization for their vaccine within the week. If approved, they say they could roll-out 100 million doses by the end o

9 views0 comments

UK Investigating If Severe Allergic Reactions Linked to Pfizer Vaccine

D. Brit

Dec 9, 2020
1 min

UK Investigating If Severe Allergic Reactions Linked to Pfizer Vaccine

What's Happening: On Wednesday, British regulators warned people that have a history of serious allergic reactions to not take the new Pfizer-BioNTech Covid-19 vaccine as they are in the process of investigating two severe reactions that occurred on the first day of the country's vaccination program. U.K.’s Medical and Healthcare Products Regulatory Agency is investigating whether the reactions are related to the vaccine. Both of the people who had adverse reactions are staff

16 views0 comments

FDA Confirms Safety and Efficacy Data for Pfizer’s COVID Vaccine

D. Brit

Dec 8, 2020
1 min

FDA Confirms Safety and Efficacy Data for Pfizer’s COVID Vaccine

What Happened: On Tuesday, an FDA advisory committee released a document confirming the efficacy and safety of Pfizer and BioNTech’s COVID-19 vaccine. The document confirmed that the vaccine’s efficacy was 95% seven days after the second dose. It also noted that the vaccine seems to provide “some protection” even after the first dose. The document also attests to the safety of the vaccine saying it was “favorable” and that the most common side effects were reactions at the in

9 views0 comments

UK Grants Emergency Use Authorization for Pfizer’s COVID Vaccine

D. Brit

Dec 2, 2020
1 min

UK Grants Emergency Use Authorization for Pfizer’s COVID Vaccine

What Happened: On Wednesday, the United Kingdom became the first Western nation to grant emergency use authorization for Pfizer and BioNTech’s COVID-19 vaccine. The emergency use authorization means the vaccine could start being distributed in limited numbers within a few days. The UK has ordered 40 million doses of the two-shot vaccine, which would be enough to vaccinate 20 million people. The government says they hope to receive 10 million doses before the end of the year.

10 views0 comments

Follow us:

Breaking News:

Subscribe to Our Newsletter

Follow us: